Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT04640402

Completed

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

COVID-19
NCT06397378

Recruiting

Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion (HPV videos)

N/A - Healthy Subjects
NCT06057025

Not yet recruiting

Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.

COVID-19
NCT05745545

Recruiting

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

SARS-CoV-2
NCT04933799

Recruiting

IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.

COVID-19 Pneumonia
NCT05313087

Completed

COVID-19 Vaccine Response in Chronic Respiratory Conditions

SARS-CoV Infection
NCT05888103

Completed

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol. (V-Mono China)

Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04091451

Completed

Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster

Herpes Zoster
NCT06799234

Active, not recruiting

Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003) (RVF003)

Rift Valley Fever
NCT04247282

Completed

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Head and Neck Cancer | Head and Neck Neoplasms
NCT03355209

Completed

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

Lennox Gastaut Syndrome
NCT04162600

Terminated

Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Rabies
NCT04543409

Terminated

A Study of Benralizumab in Patients With Eosinophilic Esophagitis (MESSINA)

Eosinophilic Esophagitis
NCT05726084

Active, not recruiting

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Coronavirus Infections | Respiratory Tract Infections | COVID-19 | COVID-19 Respiratory Infection
NCT01933048

Completed

Self-Administered Nasal Influenza Feasibility Study (SNIF)

Influenza
NCT04041570

Completed

Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults

Ebola Virus
NCT03658629

Terminated

Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults

Influenza, Human
NCT01600079

Completed

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Herpes Zoster | Shingles
NCT03578120

Completed

Immunising Mums Against Pertussis 3 (iMAP3)

Whooping Cough | Immunization; Infection | Maternal Vaccine Exposure
NCT00000746

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

HIV Infections
NCT01058850

Terminated

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

Brain Cancer | Pontine Tumors | Brain Stem Tumors
NCT02370069

Completed

The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13

Chronic Kidney Diseases
NCT04342897

Terminated

A Study of LY3127804 in Participants With COVID-19

COVID-19 | Pneumonia
NCT04534803

Withdrawn

BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)

Covid19
NCT04024800

Active, not recruiting

Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer (NSABP FB-14)

Triple-negative Breast Cancer
NCT02927444

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

Pneumococcal Infections
NCT00892775

Completed

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Measles | Rubella | Mumps | Varicella
NCT02339207

Completed

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Chronic Hepatitis C
NCT02862106

Completed

Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Chronic Hepatitis B
NCT02704533

Completed

Sequential Optimization of Dose and Schedule of PfSPZ Vaccine

Malaria
NCT03078738

Completed

Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects

Healthy Volunteers
NCT00825162

Completed

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

Influenza
NCT02628054

Completed

Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers

Typhoid Vaccine on Sleep
NCT02100436

Completed

Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations

Influenza
NCT03160820

Completed

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Measles | Rubella | Mumps | Adverse Event Following Immunisation
NCT01629667

Terminated

A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
NCT00398073

Completed

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Intraocular Melanoma | Melanoma (Skin)
NCT01653249

Completed

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

Human Papillomavirus
NCT00092417

Completed

Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)

Healthy
NCT00092495

Completed

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Cervical Cancer | Genital Warts
NCT01605864

Completed

Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia (CAP)

Community Acquired Bacterial Pneumonia
NCT00137605

Completed

Early Versus Delayed Pneumococcal Vaccination in HIV

Pneumococcal Infections
NCT02040402

Completed

Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7

Infectious Disease
NCT01488188

Completed

Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route

Healthy
NCT01591434

Completed

Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers

Leg Ulcer
NCT01091298

Completed

A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers

Rotavirus Gastroenteritis
NCT04664023

Completed

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution (BIOMARK-COVID)

Covid19
NCT03785613

Completed

Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch

Pain
NCT00020254

Completed

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Prostate Cancer
NCT00003386

Terminated

Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Ovarian Cancer

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations